A national database study found substantial variation in how clinicians manage people hospitalized with pulmonary arterial hypertension (PAH) who presented with shock, a life-threatening lack of blood flow to the body’s organs. Researchers identified 25 different initial treatment strategies involving vasoactive medications, drugs that adjust blood pressure and heart…
Discussion
Measurements that look at the interplay between the pulmonary arteries and the heart may help predict the likelihood of survival among people with all forms of pulmonary hypertension (PH), according to a study. These measurements were able to predict mortality risk even in mild PH, whereas conventional disease severity…
Discussion
When it comes to scheduling appointments, I say the earlier the better. I love first-thing-in-the-morning physical therapy sessions. The commute is quieter, as my neighborhood and city are still waking up, and the late-summer heat hasn’t yet turned the concrete into hot stones. There’s a sense of accomplishment in finishing…
Discussion
Mosliciguat, an inhaled treatment being developed by Pulmovant, was well tolerated and more effective than a placebo at improving blood flow through the lungs of adults with pulmonary hypertension associated with interstitial lung disease (PH-ILD), supporting its move into Phase 3 clinical testing, which is already underway. That’s…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
